Jun 19, 2026
15 MIN READ

Wegovy® Dosage: Unpacking Your Weekly Path to Sustainable Weight Loss

Semaglutide follows a structured four-week titration schedule starting at 0.25 mg, increasing gradually to help your body adapt while minimizing side effects and supporting long-term weight management success.

GLP-1 weight loss starts at $129/mo Provider-reviewed options. No membership fees.

See if you qualify →

Jun 19, 2026
15 MIN READ

wegovy® dosage: unpacking your weekly path to sustainable weight loss — PlexusDx GLP-1 education

Last reviewed: June 20, 2026

Last updated: June 20, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide represents a breakthrough in weight management, with clinical trials showing average weight loss of 15% over 68 weeks when paired with lifestyle changes. Unlike many other medications, semaglutide uses a gradual dosing approach—your dose increases step-by-step over several weeks—allowing your body time to adjust while building sustainable results. PlexusDx provides access to compounded semaglutide injections from licensed 503A pharmacies, allowing you to follow this proven pathway at an accessible price.

Understanding the Standard Semaglutide Dosing Schedule

Semaglutide begins with a low starting dose that increases every seven days for four consecutive weeks. Week one introduces your body to 0.25 mg, establishing tolerance before any systemic effects develop. Weeks two through four escalate to 0.5 mg, 1.0 mg, and 1.7 mg respectively, creating a gentle progression your metabolic system can adapt to without overwhelming side effects.

This deliberate titration strategy differs sharply from fixed-dose approaches because it respects individual variation in how quickly people respond to appetite-suppressing medications. Your weekly injection on the same day helps establish a predictable rhythm, making compliance easier and allowing you to track changes in hunger signals and energy levels with confidence. Most patients report that gradual escalation produces fewer gastrointestinal concerns compared to rapid dose jumps.

What Happens During Each Week of Your Titration Phase

During week one at 0.25 mg, you may notice mild appetite reduction without dramatic changes in eating patterns or digestion. This foundation dose signals your GLP-1 receptors—nerve endings that regulate hunger—to begin responding, yet remains low enough that nausea or constipation rarely develop. Most patients feel calm and motivated during this introductory period, setting positive expectations for the weeks ahead.

Weeks two and three bring the dose to therapeutic levels where meaningful appetite suppression emerges. At 0.5 mg and then 1.0 mg, you'll likely observe decreased interest in snacking, smaller meal portions, and reduced cravings for high-calorie foods. Your body's glucose-regulating systems begin responding more robustly, stabilizing blood sugar and reducing energy crashes that typically trigger overeating.

Week four reaches 1.7 mg, the dose at which most clinical benefit occurs in published trials. By this point, your digestive system has acclimated to the medication's effects, and you've developed firsthand understanding of how your unique physiology responds. Some patients remain at 1.7 mg long-term; others advance to higher maintenance doses under provider guidance, but PlexusDx emphasizes that your dose may increase while your monthly price remains flat.

Why Gradual Dose Increases Lead to Better Long-Term Results

Rapid semaglutide escalation triggers nausea and appetite loss so severe that many patients struggle with food aversion and nutritional gaps. Gradual titration produces the appetite suppression you want while preserving your ability to enjoy eating and absorb adequate protein and micronutrients. Research published in obesity journals confirms that patients completing slow titration protocols report higher medication satisfaction and lower dropout rates due to side effects.

Your body's metabolic memory also responds better to gradual change. Slow dose increases allow your insulin sensitivity to improve organically, your gut hormones to rebalance naturally, and your brain's hunger centers to recalibrate without shock. This biological foundation makes it easier to maintain weight loss once you stop semaglutide, because your nervous system has learned new set-point expectations rather than relying solely on medication to suppress appetite.

PlexusDx works with patients to respect this biological reality: sustainable weight loss requires patience during the first month while titration unfolds. After that foundation phase, many patients experience accelerating progress as the medication's full effects take hold and behavioral changes deepen.

Personalization: How PlexusDx Optimizes Your Semaglutide Pathway

Standard dosing works for most patients, but individual genetics influence how efficiently your body processes semaglutide and responds to its appetite-suppressing signals. The PlexusDx Precision Peptide Genetic Test examines key variants including the GLP1R rs6923761 position and GIPR rs1800437, revealing whether your genetic profile suggests stronger, standard, or more gradual responses to this medication. This insight, available as a $99 add-on after your first month of treatment, helps your provider optimize your dose trajectory and predict which nutrition or exercise adjustments may amplify results.

Patients with genetic predispositions toward higher hunger-hormone sensitivity often benefit from maintaining slightly lower semaglutide doses longer, while those with genetic factors suggesting rapid medication metabolism may advance doses more quickly or require higher maintenance levels. PlexusDx maps 14 metabolic pathways and 49 peptides to create a personalized blueprint, ensuring your semaglutide experience reflects your unique biology rather than a one-size-fits-all protocol.

Because PlexusDx maintains flat monthly pricing—starting at $149 for compounded semaglutide regardless of dose level—you can explore personalized dosing without financial barriers. Your dose may need to go up; your price won't, allowing genetic insights to drive clinical decisions rather than insurance constraints.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Can I start semaglutide at a higher dose to see results faster?

Starting above 0.25 mg significantly increases nausea, vomiting, and constipation risk without accelerating weight loss timeline. The four-week titration schedule reflects clinical evidence that gradual increases produce better tolerability and adherence, ultimately delivering superior long-term results than rapid escalation.

What does clinical evidence say about semaglutide's weight loss outcomes?

The STEP trials demonstrated average weight loss of 15% over 68 weeks when semaglutide is combined with behavioral modification. Patients who remained on medication longer showed sustained loss, while those discontinuing regained weight more slowly than historically seen with other approaches, suggesting metabolic benefits persist beyond the medication period.

How much does PlexusDx semaglutide cost monthly?

PlexusDx compounded semaglutide injections start at $149 per month across all dose levels, with no membership or insurance requirement. The medication comes from licensed 503A compounding pharmacies, and pricing remains flat whether you're in week one at 0.25 mg or maintaining 2.4 mg long-term.

Are there serious side effects I should watch during titration?

Nausea, constipation, and mild dizziness occur most frequently during weeks one and two but typically diminish as your body adapts. Serious side effects like pancreatitis or gallbladder issues are rare; contact your provider immediately if you experience severe abdominal pain, persistent vomiting, or signs of dehydration.

How can PlexusDx genetic testing improve my semaglutide experience?

The Precision Peptide Genetic Test examines variants like GLP1R rs6923761 that influence your receptor sensitivity to semaglutide, helping predict whether you'll respond optimally at standard doses or benefit from personalized adjustments. This $99 test adds precise data to your provider's dosing decisions, maximizing your weight loss potential based on your actual biology.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves